Login / Signup

Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.

Amy A KirkhamD Ian PatersonCarla M PradoJohn R MackeyKerry S CourneyaEdith PituskinRichard B Thompson
Published in: BMC cancer (2018)
ClinicalTrials.gov NCT03131024; 4/21/18.
Keyphrases
  • phase ii
  • randomized controlled trial
  • early breast cancer
  • clinical trial
  • open label
  • study protocol
  • physical activity
  • systematic review
  • phase iii
  • double blind
  • placebo controlled
  • body composition